Cuesta Manuel J, García de Jalón Elena, Sánchez-Torres Ana M, Gil-Berrozpe Gustavo J, Aranguren Lidia, Gutierrez Gerardo, Corrales Asier, Zarzuela Amalia, Ibañez Berta, Peralta Víctor
Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Psychol Med. 2024 Jul;54(10):2435-2443. doi: 10.1017/S0033291724000576. Epub 2024 Mar 20.
First-episode psychotic disorders comprise a heterogeneous phenotype with a complex etiology involving numerous common small-effect genetic variations and a wide range of environmental exposures. We examined whether a family of schizophrenia spectrum disorder (FH-Sz) interacts with an environmental risk score (ERS-Sz) regarding the outcome of patients with non-affective first episode psychosis (NAFEP).
We included 288 patients with NAFEP who were evaluated after discharge from an intensive 2-year program. We evaluated three outcome measures: symptomatic remission, psychosocial functioning, and personal recovery. We analyzed the main and joint associations of a FH-Sz and the ERS-Sz on the outcomes by using the relative excess risk due to interaction (RERI) approach.
A FH-Sz showed a significant association with poor symptomatic remission and psychosocial functioning outcomes, although there was no significant interaction between a FH-Sz and the ERS-Sz on these outcomes. The ERS-Sz did not show a significant association with poor symptomatic remission and psychosocial functioning outcomes, even though the magnitude of the interaction between ERS-Sz and FH-Sz with the later outcome was moderate (RERI = 6.89, 95% confidence interval -16.03 to 29.81). There was no association between a FH-Sz and the ERS-Sz and personal recovery.
Our results provide further empirical support regarding the contribution of FH-Sz to poor symptomatic remission and poor psychosocial functioning outcomes in patients with NAFEP.
首发精神障碍是一种异质性表型,其病因复杂,涉及众多常见的小效应基因变异和广泛的环境暴露。我们研究了精神分裂症谱系障碍家族(FH-Sz)与环境风险评分(ERS-Sz)在非情感性首发精神病(NAFEP)患者预后方面是否存在相互作用。
我们纳入了288例NAFEP患者,这些患者在接受为期2年的强化治疗项目出院后接受了评估。我们评估了三项预后指标:症状缓解、社会心理功能和个人康复。我们采用交互作用所致相对超额风险(RERI)方法分析了FH-Sz和ERS-Sz对预后的主要和联合关联。
FH-Sz与症状缓解不良和社会心理功能预后显著相关,尽管FH-Sz和ERS-Sz在这些预后方面没有显著的相互作用。ERS-Sz与症状缓解不良和社会心理功能预后没有显著关联,尽管ERS-Sz与FH-Sz在后者预后方面的相互作用程度适中(RERI = 6.89,95%置信区间 -16.03至29.81)。FH-Sz和ERS-Sz与个人康复之间没有关联。
我们的结果为FH-Sz对NAFEP患者症状缓解不良和社会心理功能预后不良的贡献提供了进一步的实证支持。